N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine

C27H22FN5 — CID 139326292

IUPACN-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine
SMILESC=C/C=N/C=C(\C)c1ccc2[nH]nc(-c3nc4c(-c5cccc(CF)c5)cccc4[nH]3)c2c1
InChIInChI=1S/C27H22FN5/c1-3-12-29-16-17(2)19-10-11-23-22(14-19)26(33-32-23)27-30-24-9-5-8-21(25(24)31-27)20-7-4-6-18(13-20)15-28/h3-14,16H,1,15H2,2H3,(H,30,31)(H,32,33)/b17-16+,29-12+
InChIKeyHKOQXGFNJDIDCE-GIPCJNGXSA-N
MW435.51 g/mol
LogP6.86
Rot. Bonds6

About N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine

N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine (PubChem CID 139326292) has the molecular formula C27H22FN5 and a molecular weight of 435.51 g/mol. Its IUPAC name is N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine.

Molecular Properties

Compound NameN-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine
PubChem CID139326292
Molecular FormulaC27H22FN5
Molecular Weight435.51 g/mol
Exact Mass435.19
IUPAC NameN-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine
SMILESC=C/C=N/C=C(\C)c1ccc2[nH]nc(-c3nc4c(-c5cccc(CF)c5)cccc4[nH]3)c2c1
InChIInChI=1S/C27H22FN5/c1-3-12-29-16-17(2)19-10-11-23-22(14-19)26(33-32-23)27-30-24-9-5-8-21(25(24)31-27)20-7-4-6-18(13-20)15-28/h3-14,16H,1,15H2,2H3,(H,30,31)(H,32,33)/b17-16+,29-12+
InChIKeyHKOQXGFNJDIDCE-GIPCJNGXSA-N
XLogP6.86
TPSA69.72 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds6
Heavy Atoms33
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500435.51
LogP ≤ 56.86
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}

Analyze N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine?
The IUPAC name of N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine (CID 139326292) is N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine.
What is the SMILES notation for N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine?
The canonical SMILES for N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine is C=C/C=N/C=C(\C)c1ccc2[nH]nc(-c3nc4c(-c5cccc(CF)c5)cccc4[nH]3)c2c1.
What is the InChIKey of N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine?
The InChIKey is HKOQXGFNJDIDCE-GIPCJNGXSA-N. The full InChI is InChI=1S/C27H22FN5/c1-3-12-29-16-17(2)19-10-11-23-22(14-19)26(33-32-23)27-30-24-9-5-8-21(25(24)31-27)20-7-4-6-18(13-20)15-28/h3-14,16H,1,15H2,2H3,(H,30,31)(H,32,33)/b17-16+,29-12+.
What are the key properties of N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine?
N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine has a molecular weight of 435.51 g/mol, XLogP of 6.86, 6 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(E)-2-[3-[4-[3-(fluoromethyl)phenyl]-1H-benzimidazol-2-yl]-1H-indazol-5-yl]prop-1-enyl]prop-2-en-1-imine is sourced from PubChem (CID 139326292), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).